5 completed, 3 recruiting, 2 unknown, 1 not yet recruiting. 7 Not applicable, 2 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 7 | Completed 4, Recruiting 2, Not yet recruiting 1 |
| Phase 2 | 2 | Completed 1, Recruiting 1 |
| Phase 1 | 1 | Unknown 1 |
Follow ADHD Predominantly Inattentive Type: new trials by email Literature Review of ADHD Predominantly Inattentive Type trials Research Report on ADHD Predominantly Inattentive Type
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The Primary Objective of This Study is to Determine Whether Positively Framed Information (PFI) on Side Effects, Compared to Negatively Framed and Extensive Information (NFI) Can Reduce the Number and Severity of Reported Adverse Events Caused by ADHD Medication in Children Aged 7 to 17 Years. Communication Strategy for Side Effect Counseling in ADHD Treatment - Attention Deficit Disorder, Attention Deficit Disorder (ADD) | Not applicable | Not yet recruiting | St. Antonius Hospital | 130 | 2025-01-25 | 2025-01-28 |
| Sertraline vs. Placebo in the Treatment of Anxiety in Children and AdoLescents With NeurodevelopMental Disorders Sertraline, Placebo - Neurodevelopmental Disorders, Autism | Phase 2 | Recruiting | Holland Bloorview Kids Rehabilitation Hospital | 130 | 2024-09-16 | 2026-07-27 |
| NeuroTrainer Cognitive Training For Academic Focus NeuroTrainer - ADHD - Combined Type, ADHD Predominantly Inattentive Type | Not applicable | Recruiting | NeuroTrainer | 155 | 2024-09-01 | 2025-06-19 |
| A Therapist Guided Internet-delivered Treatment for Adults With ADHD (Attention Deficit / Hyperactivity Disorder) - an Open Effectiveness Trial in Routine Care MinADHD - ADHD, ADHD - Combined Type | Not applicable | Recruiting | Haukeland University Hospital | 200 | 2024-01-01 | 2025-08-26 |
| Psychosocial ADHD Interventions - Brief Parent Training Brief behavioral parent training - ADHD, ADHD - Combined Type | Not applicable | Completed | Accare | 28 | 2021-03-16 | 2024-01-10 |
| Technology-Enhanced Executive Functioning Intervention for ADHD Homework Organization and Planning Skills (HOPS) Intervention, Digital Health Application (Online Platform) for Encouraging Skills Practice - ADHD, Attention Deficit Hyperactivity Disorder | Phase 1 | Unknown | Children's National Research Institute | 60 | 2021-02-03 | 2023-02-21 |
| Ocular-vestibular Biomarker Identification for ADHD EYE-SYNC - ADHD - Combined Type, ADHD | Unknown | Sync-Think, Inc. | 240 | 2020-07-16 | 2020-10-23 | |
| Cognitive-Behavioral Therapy for Adults With Attention-Deficit/Hyperactivity Disorder Inattentive Presentation Cognitive-behavioral therapy (Hesslinger protocol), Cognitive-behavioral therapy (CADDI protocol) - ADHD Predominantly Inattentive Type | Not applicable | Completed | Karolinska Institutet | 108 | 2019-09-01 | 2025-03-04 |
| Cognitive Impairment in Pediatric Onset Multiple Sclerosis Attention Processing Training program (APT), nonspecific computer training (n-ST) - Pediatric Onset Multiple Sclerosis, ADHD Predominantly Inattentive Type | Not applicable | Completed | Pietro Iaffaldano | 36 | 2015-09-15 | 2017-06-19 |
| Study Comparing Two Doses of MG01CI and Placebo in Adults With Predominantly Inattentive Attention Deficit Hyperactivity Disorder Metadoxine (MG01CI), Placebo - ADHD Predominantly Inattentive Type | Phase 2 | Completed | Alcobra Ltd. | 36 | 2013-08-01 | 2014-01-14 |
| The Effect of Methylphenidate Treatment in Familial Attention Deficit/Hyperactivity Disorder (ADHD) Methylphenidate- Ritalin IR (Immediate Release) - Attention Deficit/Hyperactivity Disorder Combined Type, ADHD Predominantly Inattentive Type | Not applicable | Completed | Sheba Medical Center | 40 | 2011-10-01 | 2023-12-18 |
Attention Deficit Disorder with Hyperactivity (11) · 22q11 Deletion Syndrome (1) · Anxiety Disorders (1) · Autism Spectrum Disorder (1) · Autistic Disorder (1) · Behavioral Symptoms (1) · DiGeorge Syndrome (1) · Drug-Related Side Effects and Adverse Reactions (1) · Fragile X Syndrome (1) · Medication Adherence (1) · Mental Disorders (1) · Neurodevelopmental Disorders (1) · Patient Compliance (1) · Problem Behavior (1) · Spasm (1)
Attention Deficit and Disruptive Behavior Disorders (11) · Mental Disorders (10) · Neurodevelopmental Disorders (10) · Behavior (2) · Nervous System Diseases (2) · Neurologic Manifestations (2) · Abnormalities, Multiple (1) · Basal Ganglia Diseases (1) · Brain Diseases (1) · Cardiovascular Abnormalities (1) · Cardiovascular Diseases (1) · Central Nervous System Diseases (1) · Chemically-Induced Disorders (1) · Child Behavior (1) · Child Development Disorders, Pervasive (1)
ALPL protein, human (1) · Cognitive Behavioral Therapy (1) · Methods (1) · Selective Serotonin Reuptake Inhibitors (1) · Sertraline (1) · metadoxine (1)
Accare (1) · Alcobra Ltd. (1) · Children's National Research Institute (1) · Haukeland University Hospital (1) · Holland Bloorview Kids Rehabilitation Hospital (1) · Karolinska Institutet (1) · NeuroTrainer (1) · Pietro Iaffaldano (1) · Sheba Medical Center (1) · St. Antonius Hospital (1) · Sync-Think, Inc. (1)
United States (3) · Israel (2) · Canada (1) · Netherlands (1) · Norway (1) · Sweden (1)
Arine Vlieger, MD, PhD (1) · Benjamin Bohman, PhD (1) · Dr. Evdokia Anagnostou (1) · Iris Manor, Dr. (1) · Jeff Nyquist, Ph.D. (1) · Prof. Doron Gothelf, MD (1)